EverSource Wealth Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$845 Sell
371
-47
-11% -$149 ﹤0.01% 3911
2025
Q4
$1.67K Sell
418
-989
-70% -$5.5K ﹤0.01% 3559
2025
Q3
$11.9K Sell
1,407
-107
-7% -$1.04K ﹤0.01% 2721
2025
Q2
$17K Buy
1,514
+313
+26% +$2.88K ﹤0.01% 2424
2025
Q1
$11.4K Buy
1,201
+676
+129% +$6.83K ﹤0.01% 2043
2024
Q4
$5.91K Sell
525
-10
-2% -$176 ﹤0.01% 2274
2024
Q3
$15.1K Buy
535
+163
+44% +$4.2K ﹤0.01% 1638
2024
Q2
$8.68K Buy
372
+102
+38% +$2.6K ﹤0.01% 1930
2024
Q1
$7.49K Hold
270
﹤0.01% 1839
2023
Q4
$8.92K Buy
270
+41
+18% +$1.16K ﹤0.01% 1607
2023
Q3
$6.24K Buy
+229
New +$6.37K ﹤0.01% 1611
2022
Q2
Sell
-421
Closed -$14K 1764
2022
Q1
$14K Hold
421
﹤0.01% 837
2021
Q4
$12K Buy
+421
New +$12.1K ﹤0.01% 886

Other funds holding EVH

EverSource Wealth Advisors's EVH Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its Evolent Health (EVH) stake by 11% in Q1 2026, selling an estimated $149 and leaving 371 shares worth $845. The position accounts for ﹤0.01% of the portfolio, ranked #3911.

EverSource Wealth Advisors first reported a position in EVH in Q4 2021 and has held it in 13 quarters since. The position peaked at $17K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • EverSource Wealth Advisors held 371 shares of Evolent Health worth $845 as of Q1 2026.
  • EverSource Wealth Advisors sold 47 Evolent Health shares in Q1 2026, an estimated $149.
  • Evolent Health made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3911 holding.
  • EverSource Wealth Advisors first reported a position in Evolent Health in Q4 2021 and has held it in 13 quarters since.
  • EverSource Wealth Advisors's Evolent Health position peaked at $17K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.